Nadine Siqueland has been the primary advisor for virtually every cold chain asset transaction in recent history. Learn how she leads the transformation of multiple healthcare sectors — benefitting investors and impacting patient lives.
SGS advises private equity investors and senior management teams on the acquisition, merging, and divesture of assets in the cold chain, medical device, gene therapy and pharmaceutical sectors. With a track record of executive leadership experience providing exceptional growth and returns for both privately held and public companies, founder Nadine Siqueland is the invaluable trusted partner to decision-makers seeking highly informed, strategic, value-driven M&A and business strategy insight. Nadine has built businesses and has been engaged by management teams and/or private equity firms in the Americas, Europe and Asia
Nadine Siqueland
Nadine has been a trailblazer in the health sciences for her entire career, harnessing market opportunities to grow successful organizations in the US, Europe and Asia. Her keen ability to lead each new engagement is derived from her many years in the industry, enhanced by her breadth of experience directing many busin
Whether you are just exploring the cold chain space or have a viable opportunity, let's have a conversation.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.